•  
  •  
  •  
  •  

2026-08-11 15:42:32

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Lemon Tree Hotels signs Second hotel in Mcleodganj
  • Axis Mutual Fund launches Axis Nifty Energy Index Fund & Axis Nifty Energy ETF NFOs offering exposure to India's evolving capital energy ecosystem
  • Websol Energy Q1FY27 Revenue up 70% YoY at Rs 373 crore; Company Prepays Entire IREDA Term Loan
  • CPPIB to Invest ₹3,000 Crore in Prestige Estates' Hospitality Arm PHVL for Up to 28% Stake
  • Krystal Integrated Services Consortium Secures ₹740 Crore Urban Wastewater Contracts in Maharashtra

Keywords Selected:  VAI

Stock Report

  • Granules Life Sciences Receives VAI Classification following US FDA Inspection
  • Classification of Unit-V of Apitoria Pharma Ltd as VAI by the US FDA
  • Eugia SEZ Pvt Ltd's injectable facility gets EIR from USFDA
  • USFDA determines inspection classification of 'Voluntary Action Indicated' for the Solid dosage manufacturing facility at Roorkee, India
  • Closure of US FDA Inspection at Alkem Laboratories Ltd's API manufacturing facility located at Mandva
  • Aurobindo Pharma Ltd receives EIR from USFDA classifying Unit IV as 'Voluntary Action Indicated'
  • Aurobindo Pharma Ltd updates on US FDA inspection at Unit 3
  • US FDA Inspection at Aurobindo Pharma Ltd's Unit XIV, Anakapalli District, Andhra Pradesh
  • USFDA completes inspection at Dr Reddy's Laboratories Ltd's Bollaram API unit
  • Bliss GVS Pharma Ltd updates on inspection by USFDA
  • Kotak General Insurance partners with actyv.ai to provide insurance products to MSMEs
  • USFDA assigns VAI classification to Jubilant Pharmova's API facility at Nanjangud
  • Aurobindo Pharma Ltd updates on US FDA Inspection at Unit I & III of APL Healthcare Limited
  • Zydus receives EIR with VAI from USFDA for its Moraiya formulations manufacturing facility
  • Karur Vysya Bank Ltd to open new branch at Kanuvai, Coimbatore
  • Aurobindo Pharma Ltd completes US FDA Inspection at its Unit VII
  • RateGain's latest RGLabs Innovation selected by US Car Rental company Malco Enterprises to Accelerate Revenue Recovery
  • Lupin's Goa Manufacturing Plant Receives EIR from US FDA

Latest Post

  • Lemon Tree Hotels signs Second hotel in Mcleodganj
  • Axis Mutual Fund launches Axis Nifty Energy Index Fund & Axis Nifty Energy ETF NFOs offering exposure to India's evolving capital energy ecosystem
  • Websol Energy Q1FY27 Revenue up 70% YoY at Rs 373 crore; Company Prepays Entire IREDA Term Loan
  • CPPIB to Invest ₹3,000 Crore in Prestige Estates' Hospitality Arm PHVL for Up to 28% Stake
  • Krystal Integrated Services Consortium Secures ₹740 Crore Urban Wastewater Contracts in Maharashtra


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025